I

International Clinical Research | Murfreesboro, TN

Research site
(Unclaimed)
Location
1035 N Highland Avenue, Murfreesboro, Tennessee, United States of America

Site insights

Top conditions

Top treatments

fezolinetant
Lebrikizumab
Baricitinib
Dupilumab
LY3009104
Ixekizumab
CC-93538
Guselkumab
Cendakimab

Parent organization

This site is a part of International Clinical Research

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 8 total trials

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS)

The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hai...

Enrolling
Hair Diseases
Alopecia
Drug: Placebo
Drug: Baricitinib

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) pre...

Active, not recruiting
Atopic Dermatitis
Drug: Lebrikizumab

Trial sponsors

Lilly logo
Astellas logo
S
Celgene logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems